These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32748196)

  • 1. Clinical significance of phenotyping and karyotyping of detecting circulating tumor cells in renal cell carcinoma using subtraction enrichment and immunostaining-fluorescence in situ hybridization (SE-iFISH).
    Tian D; Zhang M; Zheng G; Zhang Y; Li Y; Lin P; Li H; Jiao W; Niu H
    Int Urol Nephrol; 2020 Dec; 52(12):2281-2287. PubMed ID: 32748196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of pancreatic circulating tumor cells using combined negative enrichment and immunostaining-fluorescence in situ hybridization.
    Gao Y; Zhu Y; Zhang Z; Zhang C; Huang X; Yuan Z
    J Exp Clin Cancer Res; 2016 Apr; 35():66. PubMed ID: 27066900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of detecting circulating tumor cells in colorectal cancer using subtraction enrichment and immunostaining-fluorescence in situ hybridization (SE-iFISH).
    Wu W; Zhang Z; Gao XH; Shen Z; Jing Y; Lu H; Li H; Yang X; Cui X; Li Y; Lou Z; Liu P; Zhang C; Zhang W
    Oncotarget; 2017 Mar; 8(13):21639-21649. PubMed ID: 28423493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced detection and comprehensive in situ phenotypic characterization of circulating and disseminated heteroploid epithelial and glioma tumor cells.
    Ge F; Zhang H; Wang DD; Li L; Lin PP
    Oncotarget; 2015 Sep; 6(29):27049-64. PubMed ID: 26267323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating tumor cells with karyotyping as a novel biomarker for diagnosis and treatment of nasopharyngeal carcinoma.
    Zhang J; Shi H; Jiang T; Liu Z; Lin PP; Chen N
    BMC Cancer; 2018 Nov; 18(1):1133. PubMed ID: 30454007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined detection and subclass characteristics analysis of CTCs and CTECs by SE-iFISH in ovarian cancer.
    Cheng H; Wang S; Luan W; Ye X; Dou S; Tang Z; Zhu H; Lin PP; Li Y; Cui H; Chang X
    Chin J Cancer Res; 2021 Apr; 33(2):256-270. PubMed ID: 34158744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of Circulating Tumor Cells in Bladder Cancer by Subtraction Enrichment and Immunostaining-fluorescence
    Yang YB; Bai YJ; Tang Y; Liu ZH; Wei Q; Han P
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Jul; 48(4):605-609. PubMed ID: 28752983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of analytic performances of Cellsearch and iFISH approach in detecting circulating tumor cells.
    Sheng Y; Wang T; Li H; Zhang Z; Chen J; He C; Li Y; Lv Y; Zhang J; Xu C; Wang Z; Huang C; Wang L
    Oncotarget; 2017 Jan; 8(5):8801-8806. PubMed ID: 28187533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of sensitive and specific detection of circulating tumor cells using negative enrichment and immunostaining-FISH.
    Li Y; Ma G; Zhao P; Fu R; Gao L; Jiang X; Hu P; Ren T; Wu Y; Wang Z; Cui Z; Yang D
    Clin Chim Acta; 2018 Oct; 485():95-102. PubMed ID: 29940145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detecting and phenotyping of aneuploid circulating tumor cells in patients with various malignancies.
    Ye Z; Ding Y; Chen Z; Li Z; Ma S; Xu Z; Cheng L; Wang X; Zhang X; Ding N; Zhang Q; Qian Q
    Cancer Biol Ther; 2019; 20(4):546-551. PubMed ID: 30572767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of phenotyping and karyotyping of circulating tumor cells in patients with advanced gastric cancer.
    Li Y; Zhang X; Ge S; Gao J; Gong J; Lu M; Zhang Q; Cao Y; Wang DD; Lin PP; Shen L
    Oncotarget; 2014 Aug; 5(16):6594-602. PubMed ID: 25026283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Circulating Tumor Cells Using Negative Enrichment Immunofluorescence and an In Situ Hybridization System in Pancreatic Cancer.
    Xu Y; Qin T; Li J; Wang X; Gao C; Xu C; Hao J; Liu J; Gao S; Ren H
    Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28333072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of circulating tumor cells detection in renal cell carcinoma with thrombus: A STROBE-compliant study.
    Ge L; Song Y; Yang F; Zhao G; Lu M; Zhang S; Ma L
    Medicine (Baltimore); 2020 May; 99(22):e20615. PubMed ID: 32481476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTCs detection from intraoperative salvaged blood in RCC-IVC thrombus patients by negative enrichment and iFISH identification: a preliminary study.
    Zhang X; Guo X; Zong Y; Xu C; Wang J; Zhang B; Liu C; Gong Y; Xue L; Ma L; Zhang S; Li Y; Zeng H
    BMC Urol; 2021 Jun; 21(1):89. PubMed ID: 34112129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive in situ co-detection of aneuploid circulating endothelial and tumor cells.
    Lin PP; Gires O; Wang DD; Li L; Wang H
    Sci Rep; 2017 Aug; 7(1):9789. PubMed ID: 28852197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Tumor Cells as a Biomarker in Pancreatic Ductal Adenocarcinoma.
    Liu H; Sun B; Wang S; Liu C; Lu Y; Li D; Liu X
    Cell Physiol Biochem; 2017; 42(1):373-382. PubMed ID: 28558380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A Rare Case of Extremely High Counts of EpCAM
    Jiang TT; Li HP; Li YC
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jul; 53(4):711-715. PubMed ID: 35871746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Karyotyping of circulating tumor cells for predicting chemotherapeutic sensitivity and efficacy in patients with esophageal cancer.
    Chen Y; Yang Z; Wang Y; Wang J; Wang C
    BMC Cancer; 2019 Jul; 19(1):651. PubMed ID: 31269908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal Strategy for Colorectal Cancer Patients' Diagnosis Based on Circulating Tumor Cells and Circulating Tumor Endothelial Cells by Subtraction Enrichment and Immunostaining-Fluorescence In Situ Hybridization Combining with CEA and CA19-9.
    Luo S; Ou Y; Zheng T; Jiang H; Wu Y; Zhao J; Zhang Z
    J Oncol; 2021; 2021():1517488. PubMed ID: 34976053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated EpCAM-independent subtraction enrichment and iFISH strategies to detect and classify disseminated and circulating tumors cells.
    Lin PP
    Clin Transl Med; 2015 Dec; 4(1):38. PubMed ID: 26718583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.